Trial intelligence / Profile preview

Entereg for postoperative ileus after radical cystectomy

NCT00708201Phase 4Completed

Sponsor
Merck & Co.
Start
Mar 2009
Primary completion
Jan 2012
Countries
1
01

Overview

A Phase 4 trial of alvimopan in postoperative ileus (POI), sponsored by Merck & Co.. Started Mar 2009; status: completed.

02

Drugs

alvimopan
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT00708201.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00708201.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call